OmniComm Systems, Inc. Expands Internationally And Launches Office In Bonn, Germany

Electronic data capture (EDC) company opens additional European location to support international and US clients conducting global clinical trials

FT. LAUDERDALE, FL – June 7, 2007 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC market place, today announced that it has opened OmniComm Europe GMBH in Bonn, Germany. OmniComm is expanding its global presence to support the increase in clinical trials being conducted by their clients internationally. The Bonn office will provide enhanced local project management and study build activities, along with sales & marketing and local language Help Desk support.

“The opening of our new OmniComm office in Bonn is a testament to the company’s commitment to superior customer service for our clients all over the world,” said Cornelis F. Wit, CEO of OmniComm Systems, Inc. “The extensive industry experience of our European staff will further benefit our international customers as we expand our global presence through local support.”

The new office is comprised of industry veterans, led by two individuals who have come to OmniComm from leading EDC vendors. The new management team will spearhead the delivery of consulting services, global clientele support and coordinate staffing as the company expands its global presence. The combined clinical trial management experience of the new management duo spans over 23 years. The team’s experience includes extensive customer support and account management experience for the pharmaceutical industry, management of customer support/local language help desk support and development and delivery of SOPs and training materials. Data management expertise includes consulting services for eCRF design for international clinical trials Phase I-IV, development of SOPs, guidelines and work instructions, development of training materials for customers in Europe and US-based offices and creation and development of database structures for clinical trials in cooperation with the data management/statistics departments of international pharmaceutical companies. The OmniComm European office will support both new and existing international clients and US companies conducting clinical trials abroad. To contact the new international office, please email infoeurope@omnicomm.com or visit the website at www.omnicomm.com.

About OmniComm

OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm’s growing base of satisfied customers is a direct result of the company’s commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm’s client intuitive pricing model allows companies that range from small to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments.

OmniComm ranked in the top 150 as one of the fastest revenue growth technology companies in North America during the last 5 years. In a market overview titled “The Promise of Next-Gen eClinical Trial Software” by Forrester Research, OmniComm was given the highest rating among its competitors for industry middleware. OmniComm Systems Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Germany, California, Maryland, New York, North Carolina and Texas.

Safe Harbor Disclaimer

Statements about OmniComm’s future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. OmniComm intends that such forward-looking statements be subject to the Safe Harbors created thereby. Since these statements involve risks and uncertainties, including but not limited to economic competitive, governmental, contractual and technological factors affecting OmniComm’s operations, markets and profitability, actual results could differ materially and adversely from the expected results.

Back